Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumoursChristian Flugel, Mohamed Abou‐El‐Enein|Nature Reviews Clinical Oncology|2022Cited by 491
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletionLeila Amini, Mohamed Abou‐El‐Enein, Shannon L. Maude et al.|Nature Reviews Clinical Oncology|2022Cited by 324